← Browse by Condition
Medical Condition

gastroesophageal junction gej cancer

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT05894824 Phase 1, Phase 2
Recruiting

T-Dxd in Combination With Ramucirumab as HER2 Low Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Enrollment
58 pts
Location
South Korea
Sponsor
Yonsei University
View Trial →